The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nanoparticles-Global Market Insights and Sales Trends 2024
Synopsis
A nanoparticle is an individual molecule that behaves as a whole unit in terms of its transport and properties. The particle size of nanoparticles is 1 to 100 nanometers. The nanoparticles are further classified according to diameter as ultrafine particles (between 1 and 100 nanometers in size), fine particles (between 100 and 2,500 nanometers), and coarse particles (2,500 and 10,000 nanometers).
The global Nanoparticles market size is expected to reach US$ 149050 million by 2029, growing at a CAGR of 7.2% from 2023 to 2029. The market is mainly driven by the significant applications of Nanoparticles in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgery Centers and Diagnostic Centers,, are propelling Nanoparticles market. Liposomes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polymer-Conjugated Drugs segment is estimated at % CAGR for the next seven-year period.
Due to a wide variety of potential applications in biomedical, optical, and electronic fields the nanoparticle research is currently an area of intense scientific research. There are various applications of nanoparticles in drug delivery. Nanotechnology is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. The expanding medical diagnostics industry, increasing growth in advance healthcare technology and high advantages in medicinal imaging applications are some of the key drivers that are fuelling the growth of global nanoparticles market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanoparticles, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanoparticles market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanoparticles market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanoparticles sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanoparticles covered in this report include Novartis, Gilead Sciences, Johnson & Johnson, Amgen, Sigma-Tau Pharmaceuticals, Abraxis Biosciences and Nano Interface Technology, etc.
The global Nanoparticles market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Gilead Sciences
Johnson & Johnson
Amgen
Sigma-Tau Pharmaceuticals
Abraxis Biosciences
Nano Interface Technology
Global Nanoparticles market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanoparticles market, Segment by Type:
Liposomes
Polymer-Conjugated Drugs
Polymeric Nanoparticles
Dendrimers
Inorganic Nanoparticles
Others
Global Nanoparticles market, by Application
Hospitals
Ambulatory Surgery Centers
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanoparticles companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A nanoparticle is an individual molecule that behaves as a whole unit in terms of its transport and properties. The particle size of nanoparticles is 1 to 100 nanometers. The nanoparticles are further classified according to diameter as ultrafine particles (between 1 and 100 nanometers in size), fine particles (between 100 and 2,500 nanometers), and coarse particles (2,500 and 10,000 nanometers).
The global Nanoparticles market size is expected to reach US$ 149050 million by 2029, growing at a CAGR of 7.2% from 2023 to 2029. The market is mainly driven by the significant applications of Nanoparticles in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgery Centers and Diagnostic Centers,, are propelling Nanoparticles market. Liposomes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polymer-Conjugated Drugs segment is estimated at % CAGR for the next seven-year period.
Due to a wide variety of potential applications in biomedical, optical, and electronic fields the nanoparticle research is currently an area of intense scientific research. There are various applications of nanoparticles in drug delivery. Nanotechnology is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. The expanding medical diagnostics industry, increasing growth in advance healthcare technology and high advantages in medicinal imaging applications are some of the key drivers that are fuelling the growth of global nanoparticles market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanoparticles, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanoparticles market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanoparticles market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanoparticles sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanoparticles covered in this report include Novartis, Gilead Sciences, Johnson & Johnson, Amgen, Sigma-Tau Pharmaceuticals, Abraxis Biosciences and Nano Interface Technology, etc.
The global Nanoparticles market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Gilead Sciences
Johnson & Johnson
Amgen
Sigma-Tau Pharmaceuticals
Abraxis Biosciences
Nano Interface Technology
Global Nanoparticles market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanoparticles market, Segment by Type:
Liposomes
Polymer-Conjugated Drugs
Polymeric Nanoparticles
Dendrimers
Inorganic Nanoparticles
Others
Global Nanoparticles market, by Application
Hospitals
Ambulatory Surgery Centers
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanoparticles companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nanoparticles
1.1 Nanoparticles Market Overview
1.1.1 Nanoparticles Product Scope
1.1.2 Nanoparticles Market Status and Outlook
1.2 Global Nanoparticles Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nanoparticles Market Size by Region (2018-2029)
1.4 Global Nanoparticles Historic Market Size by Region (2018-2023)
1.5 Global Nanoparticles Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nanoparticles Market Size (2018-2029)
1.6.1 North America Nanoparticles Market Size (2018-2029)
1.6.2 Europe Nanoparticles Market Size (2018-2029)
1.6.3 Asia-Pacific Nanoparticles Market Size (2018-2029)
1.6.4 Latin America Nanoparticles Market Size (2018-2029)
1.6.5 Middle East & Africa Nanoparticles Market Size (2018-2029)
2 Nanoparticles Market by Type
2.1 Introduction
2.1.1 Liposomes
2.1.2 Polymer-Conjugated Drugs
2.1.3 Polymeric Nanoparticles
2.1.4 Dendrimers
2.1.5 Inorganic Nanoparticles
2.1.6 Others
2.2 Global Nanoparticles Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nanoparticles Historic Market Size by Type (2018-2023)
2.2.2 Global Nanoparticles Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nanoparticles Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nanoparticles Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nanoparticles Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nanoparticles Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nanoparticles Revenue Breakdown by Type (2018-2029)
3 Nanoparticles Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgery Centers
3.1.3 Diagnostic Centers
3.2 Global Nanoparticles Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nanoparticles Historic Market Size by Application (2018-2023)
3.2.2 Global Nanoparticles Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nanoparticles Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nanoparticles Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nanoparticles Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nanoparticles Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nanoparticles Revenue Breakdown by Application (2018-2029)
4 Nanoparticles Competition Analysis by Players
4.1 Global Nanoparticles Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanoparticles as of 2022)
4.3 Date of Key Players Enter into Nanoparticles Market
4.4 Global Top Players Nanoparticles Headquarters and Area Served
4.5 Key Players Nanoparticles Product Solution and Service
4.6 Competitive Status
4.6.1 Nanoparticles Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Nanoparticles Products, Services and Solutions
5.1.4 Novartis Nanoparticles Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Gilead Sciences
5.2.1 Gilead Sciences Profile
5.2.2 Gilead Sciences Main Business
5.2.3 Gilead Sciences Nanoparticles Products, Services and Solutions
5.2.4 Gilead Sciences Nanoparticles Revenue (US$ Million) & (2018-2023)
5.2.5 Gilead Sciences Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Nanoparticles Products, Services and Solutions
5.3.4 Johnson & Johnson Nanoparticles Revenue (US$ Million) & (2018-2023)
5.3.5 Amgen Recent Developments
5.4 Amgen
5.4.1 Amgen Profile
5.4.2 Amgen Main Business
5.4.3 Amgen Nanoparticles Products, Services and Solutions
5.4.4 Amgen Nanoparticles Revenue (US$ Million) & (2018-2023)
5.4.5 Amgen Recent Developments
5.5 Sigma-Tau Pharmaceuticals
5.5.1 Sigma-Tau Pharmaceuticals Profile
5.5.2 Sigma-Tau Pharmaceuticals Main Business
5.5.3 Sigma-Tau Pharmaceuticals Nanoparticles Products, Services and Solutions
5.5.4 Sigma-Tau Pharmaceuticals Nanoparticles Revenue (US$ Million) & (2018-2023)
5.5.5 Sigma-Tau Pharmaceuticals Recent Developments
5.6 Abraxis Biosciences
5.6.1 Abraxis Biosciences Profile
5.6.2 Abraxis Biosciences Main Business
5.6.3 Abraxis Biosciences Nanoparticles Products, Services and Solutions
5.6.4 Abraxis Biosciences Nanoparticles Revenue (US$ Million) & (2018-2023)
5.6.5 Abraxis Biosciences Recent Developments
5.7 Nano Interface Technology
5.7.1 Nano Interface Technology Profile
5.7.2 Nano Interface Technology Main Business
5.7.3 Nano Interface Technology Nanoparticles Products, Services and Solutions
5.7.4 Nano Interface Technology Nanoparticles Revenue (US$ Million) & (2018-2023)
5.7.5 Nano Interface Technology Recent Developments
6 North America
6.1 North America Nanoparticles Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nanoparticles Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nanoparticles Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nanoparticles Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nanoparticles Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nanoparticles Market Dynamics
11.1 Nanoparticles Industry Trends
11.2 Nanoparticles Market Drivers
11.3 Nanoparticles Market Challenges
11.4 Nanoparticles Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
